Janet Englund
Pediatric Infectious Diseases · Seattle, WANPI 1679663561
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $201,322 of the $247,598 with a category attached, or 81.3%. 12 manufacturers reported payments, led by Modernatx, Inc. at 32.5% of the total. 2025 is the largest year on record at $90,474, 5.2 times the $17,280 reported in 2019.
Across 131 payments — averaging $1890.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$81K
- Pfizer$45K
- Astrazeneca UK Limited$26K
- Merck$26K
- Sanofi Pasteur Inc.$22K
- GSK$15K
- plus $32K from 6 others
Across 277 payments — averaging $21,074 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$5.3M
- AstraZeneca$189K
- GSK$173K
- Astrazeneca UK Limited$112K
- Merck$62K
- Modernatx, Inc.$41K
- plus $7K from 1 others
What the payments were for
- Consulting fees$201,32281%
- Speaking & faculty fees$14,3616%
- Travel & lodging$30,25012%
- Food & beverage$1,6511%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 8 | $80,525 |
| Pfizer(2 entities) | 15 | $45,187 |
| Astrazeneca UK Limited | 18 | $26,272 |
| Merck | 30 | $26,173 |
| Sanofi Pasteur Inc. | 19 | $22,214 |
| GSK | 14 | $15,457 |
| Shionogi Inc | 1 | $9,440 |
| AstraZeneca | 17 | $7,994 |
| Teva Pharmaceuticals USA, Inc. | 1 | $4,225 |
| Genentech, Inc. | 4 | $4,202 |
| AbbVie | 3 | $3,750 |
| Janssen Global Services, LLC | 1 | $2,160 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Moderna Covid-19 Vaccine$40,740
- ABRYSVO$19,699
- COMIRNATY$19,375
- EVUSHELD$11,391
- S-337395$9,440
- FLUMIST QUADRIVALENT$4,600
- Xofluza$4,202
- MK-4482$2,975
- ENFLONSIA$2,610
- NO PRODUCT DISCUSSED$2,084
- PREVYMIS$2,056
- FLUMIST$1,600
- PAXLOVID$1,200
How this compares
Too few pediatric infectious diseases providers in Washingtonto place this figure against a meaningful peer group, so we don't.
Other pediatric infectious diseases in Seattle
- Alpana WaghmareSeattle$20K
- Tamara PozosSeattle$8K
- Surabhi VoraSeattle$4K
- Horacio DuarteSeattle$2K
- Michael GilbertSeattle$365
- Theresa BartonSeattle$80
- Christopher WilsonSeattle$68
- Erin ChungSeattle$51
- Sara KimSeattle$43
- Soren GanttSeattle$34
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.